News

Blink Charging Co. (BLNK) reported a narrower-than-expected loss in the fourth quarter of 2024, but revenue fell short of estimates. The company's shares rose in after-hours trading on Thursday, suggesting investors were encouraged by the narrower loss and the company's focus on profitability and global expansion.

CervoMed's neflamapimod, a potential treatment for dementia with Lewy bodies (DLB), has shown promising results in the first 16 weeks of a Phase 2b study extension. The new capsule formulation of the drug demonstrated positive benefits compared to both placebo and the old capsule formulation in terms of reducing dementia severity and improving patient condition.

The SEC's lawsuit against Ripple Labs over the alleged $1.3 billion unregistered XRP sale may be nearing its end, with the agency potentially classifying XRP as a commodity rather than a security. This shift in stance could have significant implications for the future of XRP and the broader cryptocurrency industry.

Perspective Therapeutics, a clinical-stage biotechnology company developing targeted radiotherapy agents for cancer treatment, has shown promising results in its Phase 1/2a trials for melanoma and neuroendocrine tumors. The company's lead programs, VMT01/02 and VMT-α-NET, have demonstrated anti-tumor activity and a favorable safety profile, suggesting significant potential in the growing field of targeted radioligand therapy.

The Consumer Price Index (CPI) rose by 2.8% year-over-year in February, marking a slight moderation compared to January's 3% increase. While some categories like TVs and Sporting Goods saw price declines, others like Appliances and Pet Food experienced increases, suggesting that inflationary pressures may be easing.